CLINICAL_TRIALS
trial_result
· 2012-11-29
Clinical Trial Update: 24 Hour IOP Lowering Efficacy of AL-3789 [Phase 2]
Summary
Phase 2 study of AL-3789 in open-angle glaucoma reports 24-hour intraocular pressure lowering efficacy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alcon Research | Conditions: Open-angle Glaucoma | Phase 2 | Status: COMPLETED